Hanyang Med Rev.
2017 May;37(1):2-9. 10.7599/hmr.2017.37.1.2.
The first-line regimens of Helicobacter pylori eradication in Korea
- Affiliations
-
- 1Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea. yesable7@gmail.com
- KMID: 2384001
- DOI: http://doi.org/10.7599/hmr.2017.37.1.2
Abstract
- Approximately half of the world's population is infected by Helicobacter pylori, which causes various gastrointestinal diseases including gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer. The conventional triple therapy, that consists of proton pump inhibitor (PPI), amoxicillin, and clarithromycin, is widely used in Korea because of high resistance rates of H. pylori against metronidazole. Recently, however, clarithromycin-resistance rates have also increased and the eradication rate of conventional triple therapy has been unacceptable. In order to increase the eradication rate of H. pylori, various regimens have been suggested. Understanding H. pylori eradication regimens will help select drugs in the management of H. pylori infection.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recent Trends of Helicobacter pylori Eradication Therapy: Focusing on First Line Treatment
- Helicobacter pylori Eradication Therapy in Korea
- Annual Eradication Rates of Helicobacter pylori Infection over 9 Years in Incheon
- Approach to Patients with Consecutive Helicobacter pylori Eradication Failure
- Eradication Rates of First-line and Second-line Therapy for Helicobacter pylori Infection in Gyeongnam Province
